AdaptHealth Corp. AHCO
5.64
0.07
1.26%
as of 25 Sep
- Market cap
- $756.7M
- P/E
- 0.0×
Follow AHCO
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
15.98 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.39 | 0.41 | 0.49 | 0.42 | |
P/FCF ratio |
5.68 | 6.14 | 8.36 | 14.31 | |
P/Operating CF |
7.52 | 7.35 | 17.24 | 9.76 | |
P/B ratio |
0.75 | 0.88 | 1.07 | 1.02 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.94 | 0.93 | 1.04 | 0.98 | |
EV/EBITDA |
4.63 | 4.96 | 5.69 | 5.78 | |
EV/Operating CF |
5.12 | 5.00 | 5.70 | 5.64 | |
EV/FCF |
13.67 | 13.71 | 17.69 | 33.18 | |
Quick Ratio |
0.69 | 0.67 | 0.59 | 0.61 | |
Current Ratio |
1.08 | 1.02 | 0.92 | 1.12 | |
Net Debt/EBITDA |
10.59 | 9.95 | 15.96 | 14.62 | |
Debt/Assets |
40.67% | 40.98% | 41.89% | 44.08% | |
Debt/Equity |
1.10 | 1.16 | 1.22 | 1.38 | |
Asset Turnover |
0.70 | 0.74 | 0.74 | 0.78 | |
Operating CF/Net income |
6.57 | (1.78) | (5.84) | (1.08) | |
Capex/Depreciation |
(0.95) | (0.46) | (1.11) | (0.63) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
10.98% | 11.12% | 11.70% | 12.98% | |
Intangible Assets out of Total Assets |
0.63 | 0.58 | 0.60 | 0.55 | |
Share Based Compensation of Revenue |
0.65% | 0.52% | 0.80% | 0.75% | |
Graham Net Nets |
(1.68) | (1.53) | (1.38) | (1.52) | |
Graham Number |
12.30 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
6.26% | (5.42%) | (5.13%) | (16.31%) | |
Free Cash Flow Yield |
17.60% | 16.30% | 11.97% | 6.99% | |
Revenue per Share |
6.06 | 7.32 | 6.04 | 5.44 | |
Operating CF per Share |
1.19 | 1.36 | 0.69 | 1.07 | |
Capex per Share |
(0.70) | (0.77) | (0.88) | (1.22) | |
Free Cash Flow per Share |
0.49 | 0.59 | (0.19) | (0.15) | |
Cash per Share |
0.59 | 0.79 | 0.35 | 0.32 | |
Shareholders Equity per Share |
12.01 | 11.29 | 11.15 | 10.18 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.01 | 11.29 | 11.15 | 10.18 | |
Free Cash Flow |
66.82 | 79.29 | (26.05) | (20.94) | |
Working Capital |
54.13 | 16.51 | (55.81) | 88.26 | |
Capital Expenditures |
(94.24) | (103.90) | (119.77) | (166.24) | |
Net Current Asset Value |
(2,033.85) | (2,061.35) | (2,222.05) | (2,157.14) | |
EV/EBIT |
11.74 | 33.11 | 46.74 | 0.00 | |
Capex to Sales |
0.11 | 0.11 | 0.15 | 0.22 | |
Net Profit Margin |
2.99% | (10.39%) | (1.96%) | (18.09%) | |
Price to Operating Income |
4.88 | 14.81 | 22.08 | 0.00 | |
| Other line items | |||||
Average Receivables |
390.77 | 389.46 | 405.21 | 391.99 | |
Average Payables |
476.04 | 495.84 | 511.29 | 526.75 | |
Average Inventory |
141.29 | 127.37 | 144.28 | 127.17 | |
Average Assets |
4,426.73 | 4,401.76 | 4,430.68 | 4,345.85 | |
Average Common Equity |
1,574.52 | 1,552.22 | 1,544.17 | 1,490.19 |
Columns are period end dates